Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
| Actual shortage: | 241 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2020-07-16 | 2020-07-30 | 120482 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2020-07-30 | 2020-08-17 | 121500 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Resolved | 2020-09-03 | 2020-09-17 | 123735 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-09-17 | 2020-11-19 | 124480 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2020-09-24 | 2020-11-12 | 125004 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2020-10-08 | 2020-11-19 | 126032 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2020-10-22 | 2020-11-12 | 126918 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2021-02-05 | 2021-03-11 | 133445 |
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2021-02-05 | 2021-03-11 | 133453 |
| TEVA-TOLTERODINE LA | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-03-18 | 2021-04-29 | 135952 |
| TEVA-HALOPERIDOL | 2MG | TABLET | Resolved | 2021-04-01 | 2021-06-10 | 136755 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2021-04-21 | 2021-05-20 | 137890 |
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2021-05-13 | 2021-05-20 | 139297 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2021-07-08 | 2023-09-24 | 142178 |
| TEVA-ROPINIROLE | 2MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142581 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Resolved | 2021-10-21 | 2022-10-18 | 147717 |
| ACT REPAGLINIDE | 2MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149606 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-01-20 | 2022-04-21 | 153156 |
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2022-01-27 | 2022-03-24 | 153736 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-02-17 | 2022-03-24 | 155155 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| RATIO-METFORMIN | 850MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120012 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |